title: How can cardiothoracic and vascular medical devices stay in the market?
abstract: Surgeons, as the consumers, must engage in commercial activity regarding medical devices since it directly has impacts on surgical practice and patient outcomes. Unique features defy traditional economic convention in this specific market partly because consumers do not usually pay directly. Greater involvement with commercial activity means better post-market surveillance of medical devices which leads to improved patient safety. The medical device industry has exhibited astonishing levels of growth and profitability reaching $398 billion on a global scale with new product development focusing on unmet clinical need. The industry has rapidly emerged within the context of an ageing population and a global surge in healthcare spending. But the market remains fragmented. The split of consumer, purchaser and payer leads to clinical need driving demand for new product development. This demand contributes to potentially large profit margins mainly contained by regulatory burden and liability issues. Demographic trends, prevalence of diseases and a huge capacity to absorb technology have sustained near unparalleled growth. To stay in the market, incremental development over the short term is essentially aided by responsiveness to demand. Disruptive product development is now more likely to come from multinational companies, in an increasingly expensive, regulated industry. Understanding healthcare organization can help explain the highly complex process of diffusion of innovations in healthcare that include medical devices. The time has come for surgeons to become actively involved with all aspects of the medical device life cycle including commercial activity and post-market surveillance. This is vital for improving patient care and ensuring patient safety.
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: Kathie A
authors: KA
authors: Wong
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: Luke
authors: L
authors: Hodgson
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK g.garas@imperial.ac.uk.
authors: George
authors: G
authors: Garas
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: George
authors: G
authors: Malietzis
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: Sheraz
authors: S
authors: Markar
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: Christopher
authors: C
authors: Rao
authors: Department of Cardiovascular Surgery, University Hospital CHUV, Lausanne, Switzerland.
authors: Ludwig K
authors: LK
authors: von Segesser
authors: Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
authors: Thanos
authors: T
authors: Athanasiou
mesh_terms: D006348:Cardiac Surgical Procedures / Q000295:instrumentation*; D004864:Equipment and Supplies / Q000600:supply & distribution*; D006801:Humans; D040541:Marketing / Q000639:trends*; D019616:Thoracic Surgical Procedures / Q000295:instrumentation*
keywords: Cardiac; Diffusion; Implementation; Industry; Innovation; Technology